GGrantIndex
← Leaderboards

James S Nowick

University Of California Irvine

$11,299,564
Attributed
$11,299,564
Total exposure
9
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.8M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,299,564 · 9

By mechanism

R01$5,288,910 · 3
RF1$4,391,799 · 2
R21$1,175,022 · 3
R56$443,833 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California Irvine

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposStructureS DiseaseBiologicalAmyloid Beta-ProteinPropertyDesignProteinsPeptidesAmyloidInsightCrosslinkMolecularAmino AcidsBeta Pleated SheetTailAbeta OligomerChemical ModelsN-TerminalLaboratoriesC-TerminalPharmaceutical PreparationsNeurodegenerative DisordersDimer

Grant awards (33)

Structural and Biological Characterization of Diverse Oligomers Derived from Abeta$431,991
R01 · FY2025 · AG · contact PI
Structural and Biological Characterization of Diverse Oligomers Derived from Abeta$72,526
R01 · FY2025 · AG · contact PI
Structural and Biological Characterization of Diverse Oligomers Derived from Abeta$440,808
R01 · FY2024 · AG · contact PI
Structural and Biological Characterization of Diverse Oligomers Derived from Abeta$48,351
R01 · FY2024 · AG · contact PI
Synthesis and Evaluation of aza-Novo29 as an Antibiotic Candidate$183,415
R21 · FY2023 · AI · contact PI
Synthesis and Evaluation of aza-Novo29 as an Antibiotic Candidate$217,095
R21 · FY2022 · AI · contact PI
Amyloidogenic Antibiotics$184,897
R21 · FY2022 · AI · contact PI
Structural and Biological Characterization of Diverse Oligomers Derived from Abeta$1,373,106
RF1 · FY2021 · AG · contact PI
Amyloidogenic Antibiotics$217,649
R21 · FY2021 · AI · contact PI
Mimicry of Amyloid Oligomers$291,405
R01 · FY2019 · GM · contact PI
Purchase of an Microwave Peptide Synthesizer$41,983
R01 · FY2019 · GM · contact PI
Antibodies Against Conformationally Defined Amyloid Oligomers in Alzheimer’s Disease$3,018,693
RF1 · FY2018 · AG · contact PI
Development of Teixobactin Analogues$443,833
R56 · FY2018 · AI · contact PI
Mimicry of Amyloid Oligomers$291,405
R01 · FY2018 · GM · contact PI
Purchase of an All-in-One Fluorescence Microscope$54,655
R01 · FY2018 · GM · contact PI
Mimicry of Amyloid Oligomers$291,405
R01 · FY2017 · GM · contact PI
Synthesis and Studies of a New Family of Antibiotics$173,486
R21 · FY2017 · AI · contact PI
Mimicry of Amyloid Oligomers$362,297
R01 · FY2016 · GM · contact PI
Synthesis and Studies of a New Family of Antibiotics$198,480
R21 · FY2016 · AI · contact PI
Mimicry of Amyloid Oligomers$81,593
R01 · FY2016 · GM · contact PI
Mimicry of Amyloid Oligomers$285,402
R01 · FY2015 · GM · contact PI
Mimicry of Amyloid Oligomers$288,926
R01 · FY2014 · GM · contact PI
Mimicry of Amyloid Oligomers$281,282
R01 · FY2013 · GM · contact PI
Mimicry of Amyloid Oligomers$276,969
R01 · FY2012 · GM · contact PI
Chemical Models of Protein beta-Sheet Interactions$98,178
R01 · FY2009 · GM · contact PI
Chemical Models of Protein beta-Sheet Interactions$252,598
R01 · FY2008 · GM · contact PI
Chemical Models of Protein beta-Sheet Interactions$254,006
R01 · FY2007 · GM · contact PI
Chemical Models of Protein beta-Sheet Interactions$262,949
R01 · FY2006 · GM · contact PI
Chemical Models of Protein beta-Sheet Interactions$285,898
R01 · FY2005 · GM
CHEMICAL MODELS OF PROTEIN BETA SHEET INTERACTIONS$196,709
R01 · FY2002 · GM
CHEMICAL MODELS OF PROTEIN BETA SHEET INTERACTIONS$191,809
R01 · FY2001 · GM
CHEMICAL MODELS OF PROTEIN BETA SHEET INTERACTIONS$187,052
R01 · FY2000 · GM
CHEMICAL MODELS OF PROTEIN BETA SHEET INTERACTIONS$18,713
R01 · FY2000 · GM